Use of Mendelian randomization to assess the causal status of modifiable exposures for rheumatic diseases

Abstract excerpt

The explosion in Mendelian randomization (MR) publications is hard to ignore and shows no signs of slowing. Clinician readers, who may not be familiar with jargon-ridden methods, are expected to discern the good from the many low-quality studies that make overconfident claims of causality or stretch the plausibility of what MR can investigate. We aim to equip readers with foundational concepts, contextualized...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Associations and Epidemiology
• Share to Rheumatoid Arthritis Research and Therapies
• Share to Systemic Lupus Erythematosus Research